Author

Ozlem Yedier-Bayram

Koç UniversityORCID 0000-0002-0991-5819Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Approach:experimental assay· 2 Approach:genetic perturbation / CRISPR· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam P. CribbsiD· 3 shared Ali Cenk AksuiD· 3 shared Tugba Bagci OnderiD· 3 shared Ahmet CingöziD· 2 shared Ayşe Derya CavgaiD· 2 shared Ebru YilmaziD· 2 shared Filiz Senbabaoglu AksuiD· 2 shared Hamzah SyediD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Adam P. CribbsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 28, 2026

Targeting CBP/p300 Overcomes Acquired Vincristine Resistance in Medulloblastoma

Göktuğ Karabiyik, Ozlem Yedier-Bayram, Feridun Aksu…·Tugba Bagci Onder

This study identifies CBP/p300 inhibition as a strategy to overcome vincristine resistance in medulloblastoma by targeting genes involved in drug resistance.

DOI 10.64898/2026.07.28.740967

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyExperimental & Molecular MedicinePeer-reviewedJun 29, 2025

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz…·Tugba Bagci Onder

The paper identifies BRPF1 as a key regulator of Taxol resistance in TNBC through genetic and chemical screens, showing its inhibition sensitizes resistant cells to chemotherapy.

10 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 9, 2025

Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma

Ezgi Yağmur Kala, Filiz Senbabaoglu Aksu, Muhammed Erdem Ercan…·Tugba Bagci Onder

This study identifies RBBP4 as a critical regulator of cell cycle progression in TMZ-resistant glioblastoma through CRISPR screens and functional analyses.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky